RE: Interesting read6 Jan 2026 16:45
AI Interpretation:
Luca & Associates AG (Europe) sold part of its holding in ImmuPharma as a result of a transfer of shares to an entity connected with its President, Dr. Robert Zimmer, rather than an outright sale for the open market.
Specifically:
Dr. Robert Zimmer, who is President and a shareholder of Luca & Associates AG, transferred 20,000,000 ordinary shares to Luca & Associates AG.
The transaction resulted in a decrease in the reported percentage of voting rights held by Luca & Associates AG, from 4.38% to 2.80% as of December 24, 2025.
This was a notifiable change in major holdings for regulatory purposes, but the underlying ownership effectively remains connected to Dr. Zimmer through his association with Luca & Associates AG.
The transaction was an internal rearrangement of share ownership related to the same core shareholder and his associated entity, rather than a divestment due to a change in investment strategy or company performance.